Global Human Liver Model Market Price 2024, Forecast To 2033
8 Mar, 2024
The human liver model market has witnessed rapid growth, expanding from $2.07 billion in 2023 to $2.33 billion in 2024, with a compound annual growth rate (CAGR) of 12.7%. This growth is attributed to factors such as advancements in biotechnology and the increasing demand for alternatives to animal testing. Looking forward, the market is expected to see rapid growth, reaching $3.79 billion by 2028, with a CAGR of 12.9%. This growth is driven by factors such as the integration of artificial intelligence and patient-derived liver models. Major trends in the forecast period include the development of 3D bioprinting innovations and enhanced vascularization in liver models, reflecting the growing importance of in vitro models in drug development and toxicity testing.
Global Human Liver Model Market Key Driver
The rising cases of liver disease are expected to drive the growth of the human liver model market. In Australia alone, around 2,905 new cases of liver cancer were diagnosed in 2022, with predictions indicating a risk of 1 in 103 individuals developing liver cancer by age 85 in 2022. This rise in liver disease cases underscores the need for innovative solutions like human liver models to advance research and drug development, consequently propelling market growth.
Get A Free Sample Of The Global Human Liver Model Market ReportGlobal Human Liver Model Market Segments
The human liver model market covered in this report is segmented –
1) Product:Liver Organoids, Liver-On-A-Chip, 2D Models, Animal Models, 3D Bioprinting
2) Application:Educational, Drug Discovery, Other Applications
3) End Users:Research Institutes, Pharmaceutical Companies, Other End Users
By Geography: The countries covered in the human liver model market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
North America was the largest region in the human liver model market in 2023. The regions covered in the human liver model market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Major Human Liver Model Industry Players
Corning Incorporated; EISCO Scientific LLC; BioIVT LLC; Cyprotex plc; Emulate Inc.; Cellink AB; Strand Life Sciences Pvt Ltd.; Nortis Inc.; InSphero AG; CN Bio Innovations Ltd.; TissUse GmbH; Ascendance Biotechnology Inc.; HemoShear Therapeutics Inc.; Cyfuse Biomedical KK; Cyfuse Biomedical; MIMETAS BV; Bio Innovations; Biopredic International Sarl; ZenBio; Hurel Corporation; Regenovo; Pandorum; Organovo Holdings Inc.; BICO Group; Hepregen Corporation; Kirkstall Ltd.; HepaLife Technologies Inc.; Cellaïon SA.
Get The Full Global Human Liver Model Market Report
Human Liver Model Market Overview
The human liver model refers to the model of dual-lobed liver of humans that is primarily in charge of filtering blood from the digestive tract. It is used to show and evaluate the toxic effects of drug candidates on the liver.